AngioDynamics, Inc. 8-K Report: Key Insights from January 16, 2025 Filing
Based on the provided section of the financial report, here are the key pieces of information extracted:
- Entity Information:
- Company Name: AngioDynamics, Inc.
- CIK Number: 0001275187
- State of Incorporation: Delaware (DE)
- SEC File Number: 000-50761
- EIN: 11-3146460
- Address: 14 Plaza Drive, Latham, NY 12110
- Phone Number: 518-795-1400
- Filing Details:
- Filing Type: Form 8-K
- Filing Date: January 16, 2025
- Stock Information:
- Common Stock Par Value: $0.01 per share
- Ticker Symbol: ANGO (listed on NASDAQ)
- Reporting Period:
- Period Start Date: January 16, 2025
- Period End Date: January 16, 2025
- XML and XBRL Context:
- The report is formatted in XBRL (eXtensible Business Reporting Language) which is commonly used for financial filings to provide structured data.
Insights:
- The filing date coincides with the reporting period, suggesting that this could be an event-driven filing or reporting of significant corporate action on that specific date.
- The presence of the Form 8-K indicates that this report may contain important events or corporate developments that are significant enough to warrant immediate disclosure to investors.
- The company is publicly traded and has a low par value for its common stock, which is typical for many companies aiming to maintain flexibility in their capital structure.
This summary provides an overview of the essential details from the financial report section provided.